Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon J Whitson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cell Stem Cell|February 4, 2017
Soil Primes the Seed: Epigenetic Landscape Drives Tumor BehaviorRamon J Whitson, Anthony E Oro
Cold Spring Harbor Perspectives in Medicine|July 3, 2014
Advanced treatment for basal cell carcinomasScott X Atwood, Ramon J Whitson, Anthony E Oro
The Journal of Investigative Dermatology|April 19, 2013
"Patch"ing up our tumor signaling knowledgeScott X Atwood, Ramon J Whitson, Anthony E Oro
Journal of Cellular Biochemistry|January 3, 2013
Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2)Ramon J Whitson, Marshall Scott Lucia, James R Lambert
Plos One|December 29, 2016
Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway InteractionsNicole M Urman, Amar Mirza, Scott X Atwood, et al.
The Journal of Investigative Dermatology|February 2, 2019
Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell CarcinomaFrançois Kuonen, Noelle E Huskey, Gautam Shankar, et al.
Nature Communications|October 9, 2020
AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinomaCatherine D Yao, Daniel Haensel, Sadhana Gaddam, et al.
The Prostate|October 21, 2014
Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostateJames R Lambert, Ramon J Whitson, Kenneth A Iczkowski, et al.
Cancer Cell|March 12, 2015
Smoothened variants explain the majority of drug resistance in basal cell carcinomaScott X Atwood, Kavita Y Sarin, Ramon J Whitson, et al.
Cancer Research|July 2, 2015
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent TumorsXuesong Zhao, Tatyana Ponomaryov, Kimberly J Ornell, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cell Stem Cell|February 4, 2017
Soil Primes the Seed: Epigenetic Landscape Drives Tumor BehaviorRamon J Whitson, Anthony E Oro
Cold Spring Harbor Perspectives in Medicine|July 3, 2014
Advanced treatment for basal cell carcinomasScott X Atwood, Ramon J Whitson, Anthony E Oro
The Journal of Investigative Dermatology|April 19, 2013
"Patch"ing up our tumor signaling knowledgeScott X Atwood, Ramon J Whitson, Anthony E Oro
Journal of Cellular Biochemistry|January 3, 2013
Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2)Ramon J Whitson, Marshall Scott Lucia, James R Lambert
Plos One|December 29, 2016
Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway InteractionsNicole M Urman, Amar Mirza, Scott X Atwood, et al.
The Journal of Investigative Dermatology|February 2, 2019
Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell CarcinomaFrançois Kuonen, Noelle E Huskey, Gautam Shankar, et al.
Nature Communications|October 9, 2020
AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinomaCatherine D Yao, Daniel Haensel, Sadhana Gaddam, et al.
The Prostate|October 21, 2014
Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostateJames R Lambert, Ramon J Whitson, Kenneth A Iczkowski, et al.
Cancer Cell|March 12, 2015
Smoothened variants explain the majority of drug resistance in basal cell carcinomaScott X Atwood, Kavita Y Sarin, Ramon J Whitson, et al.
Cancer Research|July 2, 2015
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent TumorsXuesong Zhao, Tatyana Ponomaryov, Kimberly J Ornell, et al.
Pageof 2